Latest filing published 20 Aug 2026 for Keros Therapeutics, Inc., €40k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Esther Cho in Keros Therapeutics, Inc. Over a trading history stretching from 18 February 2026 to 18 August 2026, the count stands at 2 filings.
On the market, this insider has only sold: 2 sales, €105k in total.
The record was last updated on 20 August 2026 with an open-market sale (€40k) in Keros Therapeutics, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations